Travere Therapeutics, Inc. Profile Avatar - Palmy Investing

Travere Therapeutics, Inc.

Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of cheno…

Biotechnology
US, San Diego [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of TVTX's Analysis
CIK: 1438533 CUSIP: 89422G107 ISIN: US89422G1076 LEI: - UEI: -
Secondary Listings
TVTX has no secondary listings inside our databases.